Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax in patients on chronic corticosteroids
NCT00546819Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- Aug 2010
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 2, randomised, double-blind trial in herpes zoster (HZ) comparing ZOSTAVAX™ with Placebo (2 arms). Primary endpoint: Number of Participants With Serious Adverse Events at 182 days. Started Oct 2007; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00546819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546819.